Image For Activity Cover
MDTW Module 3: Beyond A1C: Understanding Time in Range, a New Continuous Glucose Monitoring–Derived Metric for Assessing Glycemia
Learning Objectives:

•Discuss the limitations of A1C in assessing glycemic management in diabetes.
•Define continuous glucose monitoring (CGM)–derived glycemia metrics such as time in range (TIR), time above range (TAR), and time below range (TBR).
•Identify the components of the ambulatory glucose profile (AGP) standardized CGM report.
•Apply a systematic approach to reviewing the AGP to guide therapeutic decision-making.

Viral N. Shah, MD
Associate Professor of Medicine and Pediatrics
Barbara Davis Center for Diabetes
University of Colorado Anschutz Medical Campus
Denver, CO

•Advisory boards: Medscape LLC and Sanofi US
•Speaker: Dexcom and Insulet Corp
•Director, Diabetes Dialog: a 3-day educational program for endocrine fellows, sponsored by Abbott, Dexcom, Eversense, Insulet, Medtronic, and Tandem
•Research funding: Abbott, Dexcom, Eli Lilly and Co., JDRF, National Institutes of Health, Novo Nordisk, Insulet, and Sanofi

Duration: 45 minutes
Availability: On-Demand
Release on 11/10/2021
Cost: FREE
Credit Offered:
0.75 CME Credit
0.75 ACPE Credit
0.75 ANCC Credit
0.75 AAPA Credit
0.75 CDR Credit
0.75 COP Credit
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright 2021. All rights reserved.
Powered By